New Zealand markets closed

Vyant Bio, Inc. (1C80.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.23200.0000 (0.00%)
At close: 08:02AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
980
666
1,148
867
Cost of revenue
1,421
1,008
1,847
1,101
Gross profit
-441
-342
-699
-234
Operating expenses
Research development
6,564
6,772
4,273
3,232
Selling general and administrative
9,472
8,798
8,424
2,717
Total operating expenses
16,036
15,570
12,697
5,949
Operating income or loss
-16,477
-15,912
-13,396
-6,183
Total other income/expenses net
84
12
-4,807
-1,932
Income before tax
-16,367
-15,807
-18,575
-8,650
Income tax expense
0
0
0
0
Income from continuing operations
-16,367
-15,807
-18,575
-8,650
Net income
-43,277
-22,690
-40,859
-8,650
Net income available to common shareholders
-43,277
-22,690
-40,859
-8,650
Basic EPS
-
-3.87
-9.03
-1.49
Diluted EPS
-
-3.87
-9.03
-1.49
Basic average shares
-
5,868
4,525
5,797
Diluted average shares
-
5,868
4,525
5,797